Lyell Immunopharma Newsroom

Lyell Immunopharma Analyst Ratings

BenzingaNov 12 06:45 ET

Mitchell Kapoor Maintains Hold Rating on Lyell Immunopharma Amid Promising IMPT-314 Results and Market Challenges

TipRanksNov 12 06:18 ET

Lyell Immunopharma Cut to Underperform From Buy by B of A Securities

Dow JonesOct 30 08:18 ET

Lyell Immunopharma Price Target Maintained With a $1.00/Share by HC Wainwright & Co.

Dow JonesOct 28 08:23 ET

Lyell Immunopharma Analyst Ratings

BenzingaOct 28 08:13 ET

H.C. Wainwright Downgrades Lyell Immunopharma(LYEL.US) to Hold Rating, Cuts Target Price to $1

Moomoo NewsOct 28 06:33 ET

Neutral Rating for Lyell Immunopharma Amid Strategic Shifts and Competitive Challenges

TipRanksOct 28 06:18 ET

Lyell Immunopharma Analyst Ratings

BenzingaAug 19 07:49 ET

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX)

TipRanksAug 19 06:22 ET

B of A Securities Maintains Buy on Lyell Immunopharma, Lowers Price Target to $6

BenzingaJun 27 13:29 ET

Lyell Immunopharma Analyst Ratings

BenzingaJun 27 06:44 ET

Bank of America Securities Keeps Their Buy Rating on Lyell Immunopharma (LYEL)

TipRanksMay 13 09:45 ET

Lyell Immunopharma Analyst Ratings

BenzingaMay 7 06:47 ET

HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $6

BenzingaFeb 29 15:21 ET

Lyell Immunopharma Analyst Ratings

BenzingaFeb 29 15:19 ET

HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $8

BenzingaNov 9, 2023 07:38 ET

Lyell Immunopharma Analyst Ratings

BenzingaNov 9, 2023 07:37 ET

Promising Financial and Clinical Prospects: A Comprehensive Buy Rating Analysis for Lyell Immunopharma

TipRanksNov 9, 2023 06:46 ET

JP Morgan Downgrades Lyell Immunopharma to Neutral, Lowers Price Target to $5

BenzingaAug 28, 2023 04:48 ET

Lyell Immunopharma Analyst Ratings

BenzingaAug 28, 2023 04:47 ET